TCW Group Inc. Buys 150,317 Shares of Teladoc Health, Inc. (NYSE:TDOC)

TCW Group Inc. boosted its position in Teladoc Health, Inc. (NYSE:TDOC) by 56.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 418,697 shares of the health services provider’s stock after acquiring an additional 150,317 shares during the quarter. TCW Group Inc.’s holdings in Teladoc Health were worth $3,806,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Versant Capital Management Inc grew its stake in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 2,441 shares during the period. Blue Trust Inc. lifted its holdings in shares of Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares in the last quarter. Signaturefd LLC increased its stake in Teladoc Health by 162.7% during the 3rd quarter. Signaturefd LLC now owns 7,535 shares of the health services provider’s stock valued at $69,000 after purchasing an additional 4,667 shares in the last quarter. KBC Group NV increased its stake in Teladoc Health by 72.3% during the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after purchasing an additional 3,714 shares in the last quarter. Finally, Westside Investment Management Inc. raised its holdings in Teladoc Health by 43.8% during the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after buying an additional 2,800 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.95% of the company’s stock.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $11.52 on Monday. The company has a market capitalization of $1.98 billion, a P/E ratio of -2.00 and a beta of 1.05. The company’s 50-day moving average is $10.55 and its 200 day moving average is $9.47. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.95.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Oppenheimer reduced their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. Royal Bank of Canada lifted their price target on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. The Goldman Sachs Group boosted their price objective on Teladoc Health from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Tuesday, February 18th. Piper Sandler restated an “overweight” rating and issued a $13.00 target price (up previously from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Finally, Barclays upped their price target on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Thirteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $11.81.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.